Literature DB >> 7731923

Entamoeba histolytica autochthonous isolates from mentally retarded Italian patients.

S Gatti1, C Cevini, L Marchi, S Novati, M Scaglia.   

Abstract

A total of 77 mentally retarded male inpatients residing in a psychiatric institution in northern Italy were screened for the presence of stool parasites, Entamoeba histolytica particularly. Parasitological stool examination showed Entamoeba spp. (E. histolytica and/or E. dispar) in 26 cases (33.7%). In vitro culture on Robinson's medium was positive in 16 cases (61.1%); in 11 cases we could stabilize and clone the isolates and proceed to electrophoretic assays. In all cases, patterns of pathogenic zymodemes were found (zymodeme II, 3 isolates; zymodeme XII, 4 isolates; zymodeme XIV, 4 isolates). All isolates were therefore identified as E. histolytica.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7731923     DOI： 10.1007/bf00931621

Source DB:  PubMed          Journal:  Parasitol Res        ISSN： 0932-0113            Impact factor:   2.289


  17 in total

1.  The reliability of Entamoeba histolytica zymodemes in clinical diagnosis.

Authors:  P G Sargeaunt
Journal:  Parasitol Today       Date:  1987-02

2.  Amebiasis in a mental institution: serologic and epidemiologic studies.

Authors:  D J Sexton; D J Krogstad; H C Spencer; G R Healy; S Sinclair; C E Sledge; M G Schultz
Journal:  Am J Epidemiol       Date:  1974-11       Impact factor: 4.897

3.  Entamoeba histolytica infection in a rehabilitation center for mentally retarded persons in Japan.

Authors:  Y Kaneda; K Nagakura; H Tachibana; T Tanaka; M Sasao
Journal:  Scand J Infect Dis       Date:  1988

4.  Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro.

Authors:  E Tannich; G D Burchard
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  Autochthonous amoebiasis in institutionalized mentally-retarded patients: preliminary evaluation of isoenzyme patterns in three isolates.

Authors:  M Scaglia; S Gatti; A Bruno; C Cevini; L Marchi; P G Sargeaunt
Journal:  Ann Trop Med Parasitol       Date:  1991-10

6.  A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.

Authors:  A Gonzalez-Ruiz; R Haque; T Rehman; A Aguirre; C Jaramillo; G Castañon; A Hall; F Guhl; G Ruiz-Palacios; D C Warhurst
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

7.  Parasitic disease control in a residential facility for the mentally retarded.

Authors:  S B Thacker; S Simpson; T J Gordon; M Wolfe; A M Kimball
Journal:  Am J Public Health       Date:  1979-12       Impact factor: 9.308

8.  An outbreak of amebiasis in an institution for the mentally retarded in Japan.

Authors:  K Nagakura; H Tachibana; T Tanaka; Y Kaneda; M Tokunaga; M Sasao; T Takeuchi
Journal:  Jpn J Med Sci Biol       Date:  1989-04

9.  A study of intestinal protozoa including non-pathogenic Entamoeba histolytica from patients in a group of mental hospitals.

Authors:  P G Sargeaunt; J E Williams
Journal:  Am J Public Health       Date:  1982-02       Impact factor: 9.308

Review 10.  A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925.

Authors:  L S Diamond; C G Clark
Journal:  J Eukaryot Microbiol       Date:  1993 May-Jun       Impact factor: 3.346
View more
  3 in total

1.  Intestinal parasites may not cause nosocomial infections in psychiatric hospitals.

Authors:  Huey-Shinn Cheng; Lian-Chen Wang
Journal:  Parasitol Res       Date:  2005-02-18       Impact factor: 2.289

2.  Prevalence and genetic diversity of Entamoeba histolytica in an institution for the mentally retarded in the Philippines.

Authors:  Windell L Rivera; Sherwin R Santos; Hiroji Kanbara
Journal:  Parasitol Res       Date:  2005-11-12       Impact factor: 2.289

Review 3.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.